2) Determine the proportion of women eligible for an extended screening interval who received a lowvalue Pap test sooner than recommended (<3 years).
3) Determine the downstream consequences of these low-value Pap tests.
• Colposcopies and Costs
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Practice Setting and EHR
5
• Urban, academic, primary care practice 
Limitations
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• Single EHR
• Single Practice Study
• Single type of cervical cancer screening overuse measured
• Definition of overuse based on professional guidelines and some may disagree
Implications of EHR-Based Overuse Measurement
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• Our methods can be replicated for other overused services
• Improve quality measures to reflect optimal use of preventive services
• Facilitates EHR-based quality improvement interventions to improve efficiency
• Cut costs by reducing use of low-value services
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• To 2-3 years if:
• 3 consecutive NIL results
• To 3 years if:
• NIL result • HPV negative
• Women ≥ 30 may extend interval:
• Screen at least every 3 years. 
Immunosuppressive Meds
